Yu Zhang

Yu Zhang

Auto-generated profile, based on publicly available information

Yu Zhang

School of Public Health, Gansu University of Traditional Chinese Medicine, Lanzhou, Gansu, People’s Republic of China

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2024 in Infection and Drug Resistance
Verified
Journal Article
Open access
PDF file
ZLZhihong Liu
Zhihong Liu
XLXiaofang Liang
Xiaofang Liang
YZYu Zhang
Yu Zhang
WDWenbo Deng
Wenbo Deng
YWYulin Wang
Yulin Wang
LWLianhua Wei
Lianhua Wei
The development of antibiotic resistance complicates the treatment of infectious diseases and is a global public health threat. However, drug repurposing can address this resistance issue and reduce research and development costs. Niclosamide is a salicylanilide compound approved by the Food and Drug Administration (FDA), and it has been used clinically for treating parasitic infections for many years. Recent studies have shown that niclosamide can inhibit bacterial and fungus activity by affecting the quorum sensing system, biofilm formation, cell membrane potential, and other mechanisms. Here, we discuss recent advances in the antimicrobial applications of niclosamide and its derivatives to provide new perspectives in treating infectious diseases.